Diagnosis and Treatment of Dystonia

Neurologic Clinics

Volumn 33, Issue 1, 2015, Pages 77-100

  Jinnah, H A ^a   Factor, Stewart A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blepharospasm; Botulinum toxin; Cervical dystonia; Deep brain stimulation; Focal hand dystonia; Meige syndrome; Oromandibular dystonia; Spasmodic dysphonia

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; AMPHETAMINE DERIVATIVE; ANTICONVULSIVE AGENT; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CANNABIDIOL; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYPROHEPTADINE; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; LITHIUM; MEXILETINE; MUSCLE RELAXANT AGENT; NABILONE; PLACEBO; RILUZOLE; TIZANIDINE; ZOLPIDEM;

ABLATION THERAPY; ARTICLE; BRAIN DEPTH STIMULATION; DOUBLE BLIND PROCEDURE; DYSTONIA; HUMAN; MUSCLE CONTRACTION; NEUROIMAGING; NEUROMODULATION; OCCUPATIONAL THERAPY; PATIENT COUNSELING; PATIENT EDUCATION; PHYSIOTHERAPY; SEGMENTAL DYSTONIA; SYSTEMATIC REVIEW (TOPIC);

DYSTONIA; HUMANS;

EID: 84918573876     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2014.09.002     Document Type: Review

References (140)

1. Fahn S. The varied clinical expressions of dystonia. Neurol Clin 1984;2:541-54.
2. Fahn S. Clinical variants of idiopathic torsion dystonia. J Neurol Neurosurg Psychiatry 1989;(Suppl):96-100.
3. Elble RJ. Defining dystonic tremor. Curr Neuropharmacol 2013;11:48-52.
4. Erro R, Rubio-Agusti I, Saifee TA, et al. Rest and other types of tremor in adultonset primary dystonia. J Neurol Neurosurg Psychiatry 2014;85:965-8.
5. Defazio G, Gigante AF, Abbruzzese G, et al. Tremor in primary adult-onset dystonia: prevalence and associated clinical features. J Neurol Neurosurg Psychiatry 2013;84:404-8.
6. Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013;28:863-73.
7. Fung VS, Jinnah HA, Bhatia K, et al. Assessment of the patient with dystonia: an update on dystonia syndromes. Mov Disord 2013;28:889-98.
8. LeDoux MS. The genetics of dystonias. Adv Genet 2012;79:35-85.
9. Lohmann K, Klein C. Genetics of dystonia: what's known? what's new? what's next? Mov Disord 2013;28:899-905.
10. LeDoux MS, Dauer WT, Warner T. Emerging molecular pathways for dystonia. Mov Disord 2013;15:968-81.
11. Thompson VB, Jinnah HA, Hess EJ. Convergent mechanisms in etiologicallydiverse dystonias. Expert Opin Ther Targets 2011;15:1387-403.
12. Neychev VK, Gross R, Lehericy S, et al. The functional neuroanatomy of dystonia. Neurobiol Dis 2011;42:185-201.
13. Lehericy S, Tijssen MA, Vidailhet M, et al. The anatomical basis of dystonia: current view using neuroimaging. Mov Disord 2013;28:944-57.
14. Prudente CN, Hess EJ, Jinnah HA. Dystonia as a network disorder: what is the role of the cerebellum? Neuroscience 2014;260:23-35.
15. Quartarone A, Hallett M. Emerging concepts in the physiological basis of dystonia. Mov Disord 2013;28:958-67.
16. Kojovic M, Parees I, Kassavetis P, et al. Secondary and primary dystonia: pathophysiological differences. Brain 2013;136:2038-49.
17. Hallett M. Pathophysiology of dystonia. J Neural Transm Suppl 2006;70:485-8.
18. Jinnah HA, Berardelli A, Comella C, et al. The focal dystonias: current views and challenges for future research. Mov Disord 2013;7:926-43.
19. Stamelou M, Lai SC, Aggarwal A, et al. Dystonic opisthotonus: a "red flag" for neurodegeneration with brain iron accumulation syndromes? Mov Disord 2013;28:1325-9.
20. Schneider SA, Aggarwal A, Bhatt MH, et al. Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology 2006;67:940-3.
21. Evatt ML, Freeman A, Factor S. Adult-onset dystonia. Handb Clin Neurol 2011; 100:481-511.
22. Schneider SA, Bhatia KP. Secondary dystonia-clinical clues and syndromic associations. Eur J Neurol 2010;17(Suppl 1):52-7.
23. Schneider SA, Bhatia KP, Hardy J. Complicated recessive dystonia parkinsonism syndromes. Mov Disord 2009;24:490-9.
24. Garcia-Cazorla A, Wolf NI, Serrano M, et al. Inborn errors of metabolism and motor disturbances in children. J Inherit Metab Dis 2009;32:618-29.
25. Stamelou M, Alonso-Canovas A, Bhatia KP. Dystonia in corticobasal degeneration: a review of the literature on 404 pathologically proven cases. Mov Disord 2012;27:696-702.
26. Wickremaratchi MM, Knipe MD, Sastry BS, et al. The motor phenotype of Parkinson's disease in relation to age at onset. Mov Disord 2011;26:457-63.
27. Lalli S, Albanese A. The diagnostic challenge of primary dystonia: evidence from misdiagnosis. Mov Disord 2010;25:1619-26.
28. McKeon A, Matsumoto JY, Bower JH, et al. The spectrum of disorders presenting as adult-onset focal lower extremity dystonia. Parkinsonism Relat Disord 2008;14:613-9.
29. Tolosa E, Compta Y. Dystonia in Parkinson's disease. J Neurol 2006; 253(Suppl 7):7-13.
30. Jankovic J. Dystonia and other deformities in Parkinson's disease. J Neurol Sci 2005;229:1-3.
31. Tiderington E, Goodman EM, Rosen AR, et al. How long does it take to diagnose cervical dystonia? J Neurol Sci 2013;335:72-4.
32. Jog M, Chouinard S, Hobson D, et al. Causes for treatment delays in dystonia and hemifacial spasm: a Canadian survey. Can J Neurol Sci 2011;38:704-11.
33. Charles PD, Adler CH, Stacy M, et al. Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy). J Neurol 2014;261:1309-19.
34. Zurowski M, Marsh L, McDonald W. Psychiatric comorbidities in dystonia: emerging concepts. Mov Disord 2013;28:914-20.
35. Kuyper DJ, Parra V, Aerts S, et al. Nonmotor manifestations of dystonia: a systematic review. Mov Disord 2011;26:1206-17.
36. Fabbrini G, Berardelli I, Moretti G, et al. Psychiatric disorders in adult-onset focal dystonia: a case-control study. Mov Disord 2010;25:459-65.
37. Lewis L, Butler A, Jahanshahi M. Depression in focal, segmental and generalized dystonia. J Neurol 2008;255:1750-5.
38. Peterson DA, Sejnowski TJ, Poizner H. Convergent evidence for abnormal striatal synaptic plasticity in dystonia. Neurobiol Dis 2010;37:558-73.
39. Quartarone A, Siebner HR, Rothwell JC. Task-specific hand dystonia: can too much plasticity be bad for you? Trends Neurosci 2006;29:192-9.
40. Candia V, Schafer T, Taub E, et al. Sensory motor retuning: a behavioral treatment for focal hand dystonia of pianists and guitarists. Arch Phys Med Rehabil 2002;83:1342-8.
41. Uswatte G, Taub E. Constraint-induced movement therapy: a method for harnessing neuroplasticity to treat motor disorders. Prog Brain Res 2013;207: 379-401.
42. Zeuner KE, Shill HA, Sohn YH, et al. Motor training as treatment in focal hand dystonia. Mov Disord 2005;20:335-41.
43. Sakai N. Slow-down exercise for the treatment of focal hand dystonia in pianists. Med Probl Perform Art 2006;21:25-8.
44. Boyce MJ, Canning CG, Mahant N, et al. Active exercise for individuals with cervical dystonia: a pilot randomized controlled trial. Clin Rehabil 2012;27: 226-35.
45. Delnooz CC, Horstink MW, Tijssen MA, et al. Paramedical treatment in primary dystonia: a systematic review. Mov Disord 2009;24:2187-98.
46. De Pauw J, Van der Velden K, Meirte J, et al. The effectiveness of physiotherapy for cervical dystonia: a systematic literature review. J Neurol 2014;261:1857-65.
47. Cogiamanian F, Barbieri S, Priori A. Novel nonpharmacologic perspectives for the treatment of task-specific focal hand dystonia. J Hand Ther 2009;22:156-61.
48. Tinazzi M, Fiorio M, Fiaschi A, et al. Sensory functions in dystonia: insights from behavioral studies. Mov Disord 2009;24:1427-36.
49. Karnath HO, Konczak J, Dichgans J. Effect of prolonged neck muscle vibration on lateral head tilt in severe spasmodic torticollis. J Neurol Neurosurg Psychiatry 2000;69:658-60.
50. Leis AA, Dimitrijevic MR, Delapasse JS, et al. Modification of cervical dystonia by selective sensory stimulation. J Neurol Sci 1992;110:79-89.
51. Pelosin E, Avanzino L, Marchese R, et al. Kinesiotaping reduces pain and modulates sensory function in patients with focal dystonia: a randomized crossover pilot study. Neurorehabil Neural Repair 2013;27:722-31.
52. Tinazzi M, Farina S, Bhatia K, et al. TENS for the treatment of writer's cramp dystonia: a randomized, placebo-controlled study. Neurology 2005;64:1946-8.
53. Zeuner KE, Bara-Jimenez W, Noguchi PS, et al. Sensory training for patients with focal hand dystonia. Ann Neurol 2002;51:593-8.
54. Pesenti A, Barbieri S, Priori A. Limb immobilization for occupational dystonia: a possible alternative treatment for selected patients. Adv Neurol 2004;94: 247-54.
55. Priori A, Pesenti A, Cappellari A, et al. Limb immobilization for the treatment of focal occupational dystonia. Neurology 2001;57:405-9.
56. Okun MS, Nadeau SE, Rossi F, et al. Immobilization dystonia. J Neurol Sci 2002; 201:79-83.
57. Meunier S, Bleton JP, Mazevet D, et al. TENS is harmful in primary writing tremor. Clin Neurophysiol 2011;122:171-5.
58. van den Dool J, Visser B, Koelman JH, et al. Cervical dystonia: effectiveness of a standardized physical therapy program; study design and protocol of a single blind randomized controlled trial. BMC Neurol 2013;13:85.
59. Jankovic J. Medical treatment of dystonia. Mov Disord 2013;28:1001-12.
60. Jankovic J. Treatment of dystonia. Lancet Neurol 2006;5:864-72.
61. Bhidayasiri R, Tarsy D. Treatment of dystonia. Expert Rev Neurother 2006;6: 863-86.
62. Goldman JG, Comella CL. Treatment of dystonia. Clin Neuropharmacol 2003;26: 102-8.
63. Cloud LJ, Jinnah HA. Treatment strategies for dystonia. Expert Opin Pharmacother 2010;11:5-15.
64. Albanese A, Barnes MP, Bhatia KP, et al. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES task force. Eur J Neurol 2006;13:433-44.
65. Balash Y, Giladi N. Efficacy of pharmacological treatment of dystonia: evidencebased review including meta-analysis of the effect of botulinum toxin and other cure options. Eur J Neurol 2004;11:361-70.
66. Pisani A, Bernardi G, Ding J, et al. Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci 2007;30:545-53.
67. Greene P, Shale H, Fahn S. Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia. Adv Neurol 1988;50:547-56.
68. Burke RE, Fahn S, Marsden CD. Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology 1986;36:160-4.
69. Sanger TD, Bastian A, Brunstrom J, et al. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. J Child Neurol 2007;22:530-7.
70. Fahn S. High dosage anticholinergic therapy in dystonia. Neurology 1983;33: 1255-61.
71. Taylor AE, Lang AE, Saint-Cyr JA, et al. Cognitive processes in idiopathic dystonia treated with high-dose anticholinergic therapy: implications for treatment strategies. Clin Neuropharmacol 1991;14:62-77.
72. Nygaard TG, Marsden CD, Fahn S. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology 1991;41:174-81.
73. Segawa M, Nomura Y, Nishiyama N. Dopa-responsive dystonia. In: Stacey MA, editor. Handbook of dystonia.NewYork: InformaHealthcare, Inc; 2008. p. 219-44.
74. Kurian MA, Gissen P, Smith M, et al. The monoamine neurotransmitter disorders: an expanding range of neurological syndromes. Lancet Neurol 2011; 10:721-33.
75. Wilder-Smith E, Tan EK, Law HY, et al. Spinocerebellar ataxia type 3 presenting as an L-DOPA responsive dystonia phenotype in a Chinese family. J Neurol Sci 2003;213:25-8.
76. Charlesworth G, Mohire MD, Schneider SA, et al. Ataxia telangiectasia presenting as dopa-responsive cervical dystonia. Neurology 2013;81:1148-51.
77. Lang AE. Dopamine agonists and antagonists in the treatment of idiopathic dystonia. Adv Neurol 1988;50:561-70.
78. Chen JJ, Ondo WG, Dashtipour K, et al. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Ther 2012;34: 1487-504.
79. Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997;48:358-62.
80. Jankovic J, Orman J. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology 1988;38:391-4.
81. Fasano A, Bove F, Lang AE. The treatment of dystonic tremor: a systematic review. J Neurol Neurosurg Psychiatry 2014;85:759-69.
82. Jankovic J, Ford J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 1983;13:402-11.
83. Strzelczyk A, Burk K, Oertel WH. Treatment of paroxysmal dyskinesias. Expert Opin Pharmacother 2011;12:63-72.
84. Greene P. Baclofen in the treatment of dystonia. Clin Neuropharmacol 1992;15: 276-88.
85. Walker RH, Danisi FO, Swope DM, et al. Intrathecal baclofen for dystonia: benefits and complications during six years of experience. Mov Disord 2000; 15:1242-7.
86. Albright AL, Barry MJ, Shafron DH, et al. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 2001;43:652-7.
87. Hou JG, Ondo W, Jankovic J. Intrathecal baclofen for dystonia. Mov Disord 2001;16:1201-2.
88. Houser MK, Soland VL, Bhatia KP, et al. Paroxysmal kinesigenic choreoathetosis: a report of 26 patients. J Neurol 1999;246:120-6.
89. Fahn S, Marsden CD. The paroxysmal dyskinesias. In: Marsden CD, Fahn S, editors. Movement disorders 3. Oxford (United Kingdom): Butterworth- Heinemann; 1994. p. 310-47.
90. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995;38:571-9.
91. Kinugawa K, Vidailhet M, Clot F, et al. Myoclonus-dystonia: an update. Mov Disord 2009;24:479-89.
92. Lucetti C, Nuti A, Gambaccini G, et al. Mexiletine in the treatment of torticollis and generalized dystonia. Clin Neuropharmacol 2000;23:186-9.
93. Ohara S, Hayashi R, Momoi H, et al. Mexiletine in the treatment of spasmodic torticollis. Mov Disord 1998;13:934-40.
94. Hallett M, Benecke R, Blitzer A, et al. Treatment of focal dystonias with botulinum neurotoxin. Toxicon 2009;54:628-33.
95. Simpson DM, Blitzer A, Brashear A, et al. Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008;70:1699-706.
96. Truong D, Dressler D, Hallet M, et al. Manual of botulinum toxin. Cambridge (United Kingdom): Cambridge University Press; 2009.
97. Jost W, Valerius KP. Pictorial atlas of botulinum toxin injection: dosage, localization, application. Berlin: Quintessence Publishing Company; 2008.
98. Marsh WA, Monroe DM, Brin MF, et al. Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia. BMC Neurol 2014;14:91.
99. Vidailhet M. Treatment of movement disorders in dystonia-choreoathetosis cerebral palsy. Handb Clin Neurol 2013;111:197-202.
100. Rana AQ, Shah R. Combination of blepharospasm and apraxia of eyelid opening: a condition resistant to treatment. Acta Neurol Belg 2012;112:95-6.
101. Aramideh M, Ongerboer de Visser BW, Brans JW, et al. Pretarsal application of botulinum toxin for treatment of blepharospasm. J Neurol Neurosurg Psychiatry 1995;59:309-11.
102. Esposito M, Fasano A, Crisci C, et al. The combined treatment with orbital and pretarsal botulinum toxin injections in the management of poorly responsive blepharospasm. Neurol Sci 2013;35:397-400.
103. Waln O, Ledoux MS. Blepharospasm plus cervical dystonia with predominant anterocollis: a distinctive subphenotype of segmental craniocervical dystonia? Tremor Other Hyperkinet Mov (N Y) 2011;2011(1). pii: 33.
104. Glass GA, Ku S, Ostrem JL, et al. Fluoroscopic, EMG-guided injection of botulinum toxin into the longus colli for the treatment of anterocollis. Parkinsonism Relat Disord 2009;15:610-3.
105. Bhidayasiri R. Treatment of complex cervical dystonia with botulinum toxin: involvement of deep-cervical muscles may contribute to suboptimal responses. Parkinsonism Relat Disord 2011;17(Suppl 1):S20-4.
106. Blitzer A. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series. Eur J Neurol 2010;17(Suppl 1):28-30.
107. Watts CC, Whurr R, Nye C. Botulinum toxin injections for the treatment of spasmodic dysphonia. Cochrane Database Syst Rev 2004;(3):CD004327.
108. Esper CD, Freeman A, Factor SA. Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy. Parkinsonism Relat Disord 2010;16:438-41.
109. Charles PD, Davis TL, Shannon KM, et al. Tongue protrusion dystonia: treatment with botulinum toxin. South Med J 1997;90:522-5.
110. Singer C, Papapetropoulos S. A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia. Parkinsonism Relat Disord 2006;12:115-8.
111. Blitzer A, Brin MF, Greene PE, et al. Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol 1989;98:93-7.
112. Gonzalez-Alegre P, Schneider RL, Hoffman H. Clinical, etiological, and therapeutic features of jaw-opening and jaw-closing oromandibular dystonias: a decade of experience at a single treatment center. Tremor Other Hyperkinet Mov (N Y) 2014;4:231.
113. Lungu C, Karp BI, Alter K, et al. Long-termfollow-up of botulinum toxin therapy for focal hand dystonia: outcome at 10 years or more. Mov Disord 2011;26:750-3.
114. Naumann M, Boo LM, Ackerman AH, et al. Immunogenicity of botulinum toxins. J Neural Transm 2013;120:275-90.
115. Brin MF, Comella CL, Jankovic J, et al. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. Mov Disord 2008;23:1353-60.
116. Moro E, Gross RE, Krauss JK. What's new in surgical treatments for dystonia? Mov Disord 2013;28:1013-20.
117. Vidailhet M, Jutras MF, Grabli D, et al. Deep brain stimulation for dystonia. J Neurol Neurosurg Psychiatry 2012;84:1029-40.
118. Mills KA, Starr PA, Ostrem JL. Neuromodulation for dystonia: target and patient selection. Neurosurg Clin N Am 2014;25:59-75.
119. Andrews C, Aviles-Olmos I, Hariz M, et al. Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes. J Neurol Neurosurg Psychiatry 2010;81:1383-9.
120. Vidailhet M, Vercueil L, Houeto JL, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 2005;352: 459-67.
121. Kupsch A, Benecke R, Muller J, et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006;355:1978-90.
122. Tagliati M, Krack P, Volkmann J, et al. Long-term management of DBS in dystonia: response to stimulation, adverse events, battery changes, and special considerations. Mov Disord 2011;26(Suppl 1):S54-62.
123. Volkmann J, Wolters A, Kupsch A, et al. Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol 2012;11:1029-38.
124. Reese R, Gruber D, Schoenecker T, et al. Long-term clinical outcome in Meige syndrome treated with internal pallidum deep brain stimulation. Mov Disord 2011;26:691-8.
125. Panov F, Gologorsky Y, Connors G, et al. Deep brain stimulation in DYT1 dystonia: a 10-year experience. Neurosurgery 2013;73:86-93.
126. Morishita T, Foote KD, Haq IU, et al. Should we consider Vim thalamic deep brain stimulation for select cases of severe refractory dystonic tremor. Stereotact Funct Neurosurg 2010;88:98-104.
127. Goto S, Shimazu H, Matsuzaki K, et al. Thalamic Vo-complex vs pallidal deep brain stimulation for focal hand dystonia. Neurology 2008;70:1500-1.
128. Fukaya C, Katayama Y, Kano T, et al. Thalamic deep brain stimulation for writer's cramp. J Neurosurg 2007;107:977-82.
129. Gross R. What happened to posteroventral pallidotomy for Parkinson's disease and dystonia? Neurotherapeutics 2008;5:281-93.
130. Arce CA. Selective denervation in cervical dystonia. In: Stacey MA, editor. Handbook of dystonia. New York: Informa Healthcare USA, Inc; 2007. p. 381-92.
131. Bertrand CM. Selective peripheral denervation for spasmodic torticollis: surgical technique, results, and observations in 260 cases. Surg Neurol 1993;40:96-103.
132. Munchau A, Palmer JD, Dressler D, et al. Prospective study of selective peripheral denervation for botulinum toxin resistant patients with cervical dystonia. Brain 2001;124:769-83.
133. Cohen-Gadol AA, Ahlskog JE, Matsumoto JY, et al. Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo clinic. J Neurosurg 2003;98:1247-54.
134. Chen X, Ma A, Liang J, et al. Selective denervation and resection of cervical muscles in the treatment of spasmodic torticollis: long-term follow-up results in 207 cases. Stereotact Funct Neurosurg 2000;75:96-102.
135. Braun V, Richter HP. Selective peripheral denervation for spasmodic torticollis: 13 year experience with 155 patients. J Neurosurg 2002;97:207-12.
136. Georgescu D, Vagefi MR, McMullan TF, et al. Upper eyelid myectomy in blepharospasm with associated apraxia of lid opening. Am J Ophthalmol 2008;145: 541-7.
137. Grivet D, Robert PY, Thuret G, et al. Assessment of blepharospasm surgery using an improved disability scale: study of 138 patients. Ophthal Plast Reconstr Surg 2005;21:230-4.
138. Pariseau B, Worley MW, Anderson RL. Myectomy for blepharospasm 2013. Curr Opin Ophthalmol 2013;24:488-93.
139. Ludlow CL. Treatment for spasmodic dysphonia: limitations of current approaches. Curr Opin Otolaryngol Head Neck Surg 2009;17:160-5.
140. Ludlow CL, Adler CH, Berke GS, et al. Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg 2008;139:495-505.